Effects of topical calcipotriol on the expression of adhesion molecules in psoriasis

Journal of Cutaneous Pathology

Volumn 25, Issue 2, 1998, Pages 89-94

  Savoia, Paola ^a   Novelli, Mauro ^a   De Matteis, Antonietta ^a   Verrone, Anna ^a   Bernengo, Maria Grazia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CELL ADHESION MOLECULE; HLA DR ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; TENASCIN;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; FEMALE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; PROTEIN EXPRESSION; PSORIASIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTIGENS, CD26; CALCITRIOL; CALCIUM; CELL ADHESION MOLECULES; DERMATOLOGIC AGENTS; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN; TREATMENT OUTCOME;

EID: 0031930013     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1998.tb01695.x     Document Type: Article

References (33)

1. Berth-Jones J, Hutchinson PE. Vitamin D analogues in psoriasis. Br J Dermatol 1992: 127: 71.
2. Bourke JF, Berth-Jones J, Iqbal SJ, Hutchinson PE. High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris. Br J Dermatol 1993: 129: 74.
3. Kragballe K, Beck HI, Sogaard H. Improvement of psoriasis by a topical vitamin D3 analogue (MC903) in a double-blind study. Br J Dermatol 1988: 119: 223.
4. De Jong EMGJ, van de Kerkhof PCM. Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with vitamin D3 analogue MC 903: modulations and interrelations. Br J Dermatol 1993: 124: 221.
5. Gerritsen MJP, Rulo HFC, Van Vlijmen-Willems I, Van Erp PEJ, Van de Kerkhof PCM. Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: a cell biological study. Br J Dermatol 1993: 128: 666.
6. Orfanos CE, Schaumburg-Lever G, Mahrle G, Lever WF. Alterations of cell surfaces as a pathogenetic factor in psoriasis. Arch Dermatol 1977: 107: 38.
7. Pellegrini G, De Luca M, Orecchia G et al. Expression, topography and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin. J Clin Invest 1992: 89: 1783.
8. Kragballe K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC903). Arch Dermatol 1989: 125: 1647.
9. Kragballe K, Gjertsen BT, de Hoop D et al. Double-blind, right-left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991: 337: 193.
10. Ramsay CA, Berth-Jones J, Brundin G et al. Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994: 189: 260.
11. Dubertet L, Wallach D, Souteyrand P et al. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. J Am Acad Dermatol 1992: 27: 983.
12. Lever WF, Schaumburg-Lever G. Histopathology of the skin. Philadelphia: Lippincot, 1990: 156.
13. Giannelli G, Savoia P, Schiraldi O et al. Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on the basis of integrin adhesion receptors. Hepatology 1994: 20: 56.
14. Marchisio PC, Bondanza S, Cremona O, Cancedda R, De Luca M. Polarized expression of integrin receptors (α6β4, α2β1, α3β1 and αvβ5) and their relationship with the cytoskeleton and basement membrane matrix in cultured human keratinocytes. J Cell Biol 1991: 112: 761.
15. De Luca M, Tamura RN, Kajiji S et al. Polarized integrin mediates human keratinocytes adhesion to basal lamina. Proc Natl Acad Sci USA 1990: 87: 6888.
16. Sonnenberg A, Calafat J, Janssen H et al. Integrin α6β4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol 1991: 113: 907.
17. Carter WG, Wayner EA, Bouchard TS, Kaur P. The role of integrins α2β1 and α3β1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 1990: 110: 1387.
18. Larjava H, Peltonen J, Akiyama SK et al. Novel function of β1 integrins in keratinocyte cell-cell adhesion. J Cell Biol 1990: 110: 803.
19. Kajiji S, Tamura RN, Quaranta V. A novel integrin (αEβ4) from human epithelial cells suggests for a fourth family of integrin adhesion receptors. EMBO J 1989: 8: 673.
20. Ryynanen J, Laakkola S, Engvall E, Peltonen J, Uitto J. Expression of β4 integrins in human skin: comparison of epidermal distribution with β1-integrin epitopes, and modulation by calcium and vitamin D3 in cultured keratinocytes. J Invest Dermatol 1991: 97: 562.
21. Savoia P, Trusolino L, Pepino E, Cremona O, Marchisio PC. Expression and topography of integrins and basement membrane proteins in epidermal carcinomas. J Invest Dermatol 1993: 101: 352.
22. Guo M, Kim LT, Akyjama AS, Gralnick SK, Yamada KM. Altered processing of integrin receptors during keratinocyte activation. Exp Cell Res 1991: 195: 315.
23. Hertle MD, Kubler MI, Leigh I, Watt FM. Aberrant integrin expression during epidermal wound healing and psoriatic epidermidis. J Clin Invest 1992: 89: 1892.
24. Singer KH, Tuck DT, Sampson HA. Epidermal keratinocytes express the adhesion molecule intercellular adhesion molecule-1 in inflammatory dermatoses. J Invest Dermatol 1989: 92: 746.
25. Adams JC, Watt FM. Changes in keratinocytes adhesion during terminal differentiation: reduction in fibronectin binding precedes α5β1 integrin loss from the cell surface. Cell 1990: 63: 425.
26. Lu I, Gilleaudeau P, McLane JA et al. Modulation of epidermal differentiation, tissue inflammation and T-lymphocyte infiltration in psoriatic plaques by topical calcitriol. J Cutan Pathol 1997: 23: 419.
27. Boisseau-Garsaud AM, Donatien P, Margerin C, Taieb A. EGF receptor expression and growth of psoriatic and normal human keratinocytes are modulate by 1.25 (OH)2-vitamin D ex vivo. Arch Dermatol Res 1996: 288: 453.
28. Reichrath J, Perez A, Muller SM et al. Topical calcitriol (1,25-dihydroxyvitamm D3) treatment of psoriasis: an immunohistological evaluation. Acta Derm Venereol 1997: 77: 268.
29. Reicherath J, Muller SM, Kerber A, Baum HP, Bahmer FA. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin. J Am Acad Dermatol 1997: 36: 19.
30. van der Vleuten CJ, de Jong EM, van de Kerkhof PC. Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol. Arch Dermatol Res 1996: 288: 366.
31. Wood GS, Michle SA, Durden F. Expression of class II major histocompatibility antigens in cutaneous T cell lymphoma. Int J Dermatol 1994: 33: 346.
32. Onuma S. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J Dermatol 1994: 21: 223.
33. Novelli M, Savoia P, Fierro MT, Verrone A, Quaglino P, Bernengo MG. Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases. Br J Dermatol 1996: 134: 1052.